Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1

Antiviral Research

Volumn 92, Issue 2, 2011, Pages 305-312

  Mishra, Yogendra Kumar ^a   Adelung, Rainer ^a   Röhl, Claudia ^a   Shukla, Deepak ^b   Spors, Frank ^c   Tiwari, Vaibhav ^d  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d MIDWESTERN UNIVERSITY   (United States)

Author keywords

Herpes simplex virus type 1 (HSV 1); Virus cell interaction; Zinc oxide structures

Indexed keywords

HEPARAN SULFATE; NANOMATERIAL; OXYGEN; ZINC OXIDE;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CELL SPREADING; CONTROLLED STUDY; CORNEA; FIBROBLAST; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; ILLUMINATION; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; VIRION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS SPIKE;

ANTIVIRAL AGENTS; CELLS, CULTURED; FIBROBLASTS; HERPESVIRUS 1, HUMAN; HUMANS; NANOPARTICLES; STATIC ELECTRICITY; VIRUS INTERNALIZATION; ZINC OXIDE;

HUMAN HERPESVIRUS 1;

EID: 80054873044     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.08.017     Document Type: Article

References (47)

1. Akhtar J., Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 2009, 276:7228-7236.
2. Baram-Pinto D., Shukla S., Gedanken A., Sarid R. Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. Small 2010, 6(9):1044-1050.
3. Beasley D.G., Meyer T.A. Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products. Am. J. Clin. Dermatol. 2010, 11:413-421.
4. Bowman M.C., Ballard T.E., Ackerson C.J., Feldheim D.L., Margolis D.M., Melander C. Inhibition of HIV fusion with multivalent gold nanoparticles. J. Am. Chem. Soc. 2008, 130(22):6896-6897.
5. Burgos J.S., Ripoll-Gomez J., Alfaro J.M., Sastre I., Valdivieso F. Zebrafish as a new model for herpes simplex virus type-1 infection. Zebrafish 2008, 5:323-333.
6. Corey L., Spear P.G. Infections with herpes simplex viruses. N. Eng. J. Med. 1986, 314:686-691.
7. Dambrosi S., Martin M., Yim K., Miles B., Canas J., Sergerie Y., Boivin G. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models. J. Med. Virol. 2010, 82:1000-1010.
8. Dean H.J., Terhune S., Shieh M.T., Susmarski N., Spear P.G. Single amino acid substitutions in gD of herpes simplex virus 1 confer resistant to gD-mediated interference and cause cell type-dependent alterations in infectivity. Virology 1994, 199:67-80.
9. Desai P., Person S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J. Virol. 1998, 72:7563-7568.
10. Hill J.M., Ball M.J., Neumann D.M., Azcuv A.M., Bhattacharjee P.S., Bouhanik S., Clement C., Lukiw W.J., Foster T.P., Kumar M., Kafman H.E., Thompson H.W. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J. Virol. 2008, 85:8230-8234.
11. Kachynski A.V., Kuzmin A.N., Nyk M., Roy I., Prasad P.N. Zinc oxide nanocrystals for non-resonant nonlinear optical microscopy in biology and medicine. J. Phys. Chem. C Nanomater Interfaces 2008, 112:10721-10724.
12. Kaps, S., Adelung, R., Wolpert, C., Preuße, T., Claus, M., Mishra, Y.K., 2010. Elastisches Material mit einem auf Partikelebene durch Nanobrücken zwischen Partikeln überbrückten, Deutsches Patentamt, 2.03.2010, DE 10 2010 012 385.4.
13. Kaye S.B., Baker K., Bonshek R., Maseruka H., Grinfeld E., Tullo A., Easty D.L., Hart C.A. Human herpesviruses in the cornea. Br. J. Opthalmol. 2000, 84:563-571.
14. Kong J., Chu S., Olmedo M., Li L., Yang Z., Liu J. Dominant ultraviolet light emissions in packed ZnO columnar homojunction diodes. Appl. Phys. Lett. 2008, 93:132113.
15. Lara H.H., Ayala-Nuñez N.V., Ixtepan-Turrent L., Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 2010, 8:1.
16. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
17. Liu J., Thorp S.C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 2002, 22:1-25.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Bio. Chem. 1951, 193:265-275.
19. Montgomery R.I., Warner M.S., Lum B.J., Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996, 87:427-436.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
21. Nyberg K., Ekblad M., Bergström T., Freeman C., Parish C.R., Ferro V., Trybala E. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res. 2004, 63:15-24.
22. Oh M.J., Akhtar J., Desai P., Shukla D. A role for heparan sulfate in viral surfing. Biochem. Biophys. Res. Commun. 2010, 391:176-181.
23. O'Donnell C.D., Shukla D. The importance of heparan sulfate in herpesvirus infection. Virol. Sin. 2008, 23:383-393.
24. O'Donnell C.D., Shukla D. A novel function of heparan sulfate in the regulation of cell-cell fusion. J. Biol. Chem. 2009, 284:29654-29665.
25. Pertel P., Fridberg A., Parish M., Spear P.G. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology 2001, 279:313-324.
26. Raghuraman A., Tiwari V., Thakkar J.N., Gunnarsson T., Shukla D., Hindle M., Desai U. Structural characterization of a serendipitously discovered bioactive macromolecule, Lignin sulfate. Biomacromolecules 2005, 6:2822-2832.
27. Raghuraman A., Tiwari V., Zhao Q., Shukla D., Debnath A.K., Desai U. Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate. Biomacromolecules 2007, 8:1759-1763.
28. Rasmussen J.W., Martinez E., Louka P., Wingett D.G. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin. Drug Deliv. 2010, 9:1063-1077.
29. Roehl C., Sievers J. Microglia is activated by astrocytes in trimethyltin intoxication. Toxicol. Appl. Pharmacol. 2005, 204:36-45.
30. Rusnati M., Urbinati C. Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis. Curr. Pharm. Des. 2009, 15:2946-2957.
31. Schulte E.C., Sauerbrei A., Hoffmann D., Zimmer C., Hemmer B., Mühlau M. Acyclovir resistance in herpes simplex encephalitis. Ann. Neurol. 2010, 67:830-833.
32. Spear P.G., Eisenberg R.J., Cohen G.H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 2000, 275:1-8.
33. Shukla D., Spear P.G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 2001, 108:503-510.
34. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999, 99:13-22.
35. Superti F., Ammendolia M.G., Marchetti M. New advances in anti-HSV chemotherapy. Curr. Med. Chem. 2008, 15:900-911.
36. Tallury P., Malhotra A., Byrne L.M., Santra S. Nanobioimaging and sensing of infectious diseases. Adv. Drug Deliv. Rev. 2010, 62(4-5):424-437.
37. Thakkar J.N., Tiwari V., Desai U.R. Nonsulfated, cinnamic acid-based lignins are potent antagonists of HSV-1 entry into cells. Biomacromolecules 2010, 11:1412-1416.
38. Tiwari V., Clement C., Duncan M.B., Chen J., Liu J., Shukla D. A role for 3-O-sulfated heparin sulfate in cell fusion induced by herpes simplex virus type 1. J. Gen. Virol. 2004, 85:805-809.
39. Tiwari V., Clement C., Xu D., Valyi-Nagy T., Yue B.Y., Liu J., Shukla D. Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. J. Virol. 2006, 80:8970-8980.
40. Tiwari V., Shukla S.Y., Shukla D. A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion. Antiviral Res. 2009, 84:67-75.
41. Tiwari V., Liu J., Valyi-Nagy T., Shukla D. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J. Biol. Chem. 2011, 286:25406-25415.
42. Travan A., Marsich E., Donati I., Benincasa M., Giazzon M., Felisari L., Paoletti S. Silver-polysaccharide nanocomposite antimicrobial coatings for methacrylic thermosets. Acta Biomater. 2010, [Epub ahead of print].
43. Vig K., Boyoglu S., Rangari V., Sun L., Singh A., Pillai S., Singh S.R. Use of nanoparticles as therapy for respiratory syncytial virus inhibition. Nanotechnology Life Sciences, Medicine & Bio Materials-Technical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show 2008, vol. 2:543-546.
44. Whitley R.J., Kimberlin D.W. Herpes simplex viruses. Clin. Infect. Dis. 1997, 26:97-109.
45. Whitley R.J., Kimberlin D.W., Roizman B. Herpes simplex viruses. Clin. Infect. Dis. 1998, 26:541-553.
46. WuDunn D., Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 1989, 63:52-58.
47. Wu J.M., Chen Yi.-R. Ultraviolet-light-assisted formation of zno nanowires in ambient air: comparison of photoresponsive and photocatalytic activities in zinc hydroxide. J. Phys. Chem. 2011, 115(5):2235-2243.